Dyslipidemia
Abnormal cholesterol and triglycerides often accompany obesity. GLP-1 medications significantly improve lipid profiles beyond what statins alone achieve.
Triglyceride reduction
20-30%
HDL increase
5-10 mg/dL
ApoB reduction
15-25%
Condition Guide
Dyslipidemia
Lipid Improvements
GLP-1 medications improve lipid profiles through weight loss and metabolic effects. Triglycerides typically drop 20-30%. HDL cholesterol increases 5-10 mg/dL. LDL particle size improves (less atherogenic). ApoB and non-HDL cholesterol decrease significantly. These improvements reduce cardiovascular risk independent of weight loss effects. Combined with statins, GLP-1s provide comprehensive lipid management.
Treatment Approach
Baseline lipid panel before starting GLP-1s. Repeat testing at 3-6 months. Continue statins if prescribed—synergistic benefits with GLP-1s. Some patients can reduce statin doses after significant weight loss. SeraVia formulations support cardiovascular health.
Frequently Asked Questions
Will GLP-1s improve my cholesterol?
Yes, significantly. Triglycerides drop 20-30%, HDL increases, and LDL quality improves. Combined with statins, comprehensive protection.
SeraVia formulations support cardiovascular health and lipid metabolism alongside GLP-1 therapy.
Learn More →Find lipid and weight management specialists
Compare pricing, reviews, and availability across 18,000+ GLP-1 providers.
Search Providers →Explore all conditions
Learn how GLP-1 medications treat different conditions — from diabetes to PCOS to cardiovascular disease.